Bortezomib Plus Dexamethasone Followed by Escalating Donor Lymphocyte Infusions for Patients with Multiple Myeloma Relapsing or Progressing after Allogeneic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Bortezomib Plus Dexamethasone Followed by Escalating Donor Lymphocyte Infusions for Patients with Multiple Myeloma Relapsing or Progressing after Allogeneic Stem Cell Transplantation

Published:2013-03 Issue:3 Volume:19 Page:424-428
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Montefusco Vittorio,Spina Francesco,Patriarca Francesca,Offidani Massimo,Bruno Benedetto,Montanari Mauro,Mussetti Alberto,Sperotto Alessandra,Scortechini Ilaria,Dodero Anna,Fanin Renato,Valagussa Pinuccia,Corradini Paolo

Funder

Fondazione Michelangelo

bortezomib supply

Janssen Cilag

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference28 articles.

1. Progress in allogeneic transplantation for multiple myeloma;Gahrton;Eur J Haematol,2010

2. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up;Björkstrand;J Clin Oncol,2011

3. Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability;Patriarca;Biol Blood Marrow Transplant,2012